NBP(NovaBridge Biosciences) 的财务报表:医疗保健,生物技术。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 科目 | FY 截至 2019-12-31 | FY 截至 2020-12-31 | FY 截至 2021-12-31 | FY 截至 2022-12-31 | FY 截至 2023-12-31 |
|---|---|---|---|---|---|
| 营业收入 | $4.35M | $223.84M | $13.66M | −$32.87M | $3.91M |
| 毛利润 | $4.35M | $223.84M | $6.45M | −$36.91M | — |
| 营业利润 | — | — | — | −$7.87M | −$10.18M |
| 净利润 | −$210.45M | $68.33M | −$361.80M | −$371.93M | −$207.19M |
| 经营现金流 | −$125.81M | $62.91M | −$151.00M | −$163.59M | −$184.46M |
| 自由现金流 | −$127.58M | $61.75M | −$155.65M | −$170.38M | −$186.07M |
| 摊薄每股收益 | $-29.16 | $0.44 | $-2.07 | $-1.96 | $-1.08 |